Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A double-blind placebo controlled trial of Ginkgo biloba added to risperidone in patients with autistic disorders.

A double-blind placebo controlled trial of Ginkgo biloba added to risperidone in patients with autistic disorders. Child Psychiatry Hum Dev. 2012 Oct; 43(5):674-82.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.